Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2017 Publisher: Accord Healthcare Limited, Sage House, 319 Pinner Road, North Harrow, Middlesex, HA1 4HF, United Kingdom
Gliclazide 40mg Tablets.
| Pharmaceutical Form |
|---|
|
Tablet. White, circular, flat, bevelled-edge uncoated tablet plain on one face and the identifying letters “GU” on the reverse. |
Each tablet contains 40mg gliclazide.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Gliclazide |
Gliclazide is a hypoglycaemic sulfonylurea antidiabetic active substance. Gliclazide reduces blood glucose levels by stimulating insulin secretion from the β-cells of the islets of Langerhans. |
| List of Excipients |
|---|
|
Microcrystalline cellulose |
Blister packs of PVC with Aluminium foil containing 20, 28, 56, 60 84, 100 tablets.
Not all pack sizes may be marketed.
Accord Healthcare Limited, Sage House, 319 Pinner Road, North Harrow, Middlesex, HA1 4HF, United Kingdom
PL 20075/0687
15/03/2016
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
